-
Are We On the Road to an HIV Vaccine?
"It only takes one virus to get through for a person to be infected," explained Dr. John Mascola. This is true of any viral infection, but in this instance, Mascola is referring to HIV and his ongoing efforts to develop a vaccine against the virus. "It's been so difficult to make an HIV/AIDS vaccine."
- Categories
- Health Care
- Tags
- vaccines
-
Race to Make Ebola Vaccine Pits Crazy Timeline Against Maddening Obstacles
Refrigeration is just one of the myriad challenges for GlaxoSmithKline Plc and other companies racing to create vaccines to fight Ebola. They’re facing issues ranging from packaging the drug in tiny glass vials for distribution, to assembling fleets of trucks and motorbikes to transport it along potholed roads, to monitoring subjects in a Swiss lakeside city to test the vaccine ultimately destined for villages in the African jungle.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Business Models, Best Practices and Measures in Access to Medicine: Index to be released Monday ranks pharmaceutical companies’ efforts to improve availability in developing countries
The Access to Medicine Index, which is published every two years and independently ranks pharmaceutical companies’ efforts to improve access to medicine in developing countries, will be released on Monday.
- Categories
- Health Care
-
Supply Chains for Global Health: Learning from Starbucks and Microsoft to get life-saving commodities where they’re needed, when they’re needed
Whether it is vaccines in Nigeria, family planning and essential medicines in Ethiopia, or HIV medications in Tanzania, supply chain managers need to have a solid understanding of product availability and supply chain processes in order to respond to people’s needs.
- Categories
- Health Care
- Tags
- supply chains, vaccines
-
Shaping the Market for Global Health Data: Why collecting information on lower-income countries should be ‘first order of business’
The most valuable currency in global health programs today is accurate and reliable data, but such data doesn’t exist for most low-income and lower-middle-income countries – primarily because it’s expensive. The authors discuss why, and how, more data might become available.
- Categories
- Health Care
-
World’s 1st dengue vaccine likely by 2015: Sanofi
As India deals with increasing number of dengue fever, pharma major Sanofi today said the world's first vaccine against the mosquito-borne viral disease may be available by the second half of 2015.
- Categories
- Health Care
-
Bill Gates-Backed Group Weighs Funding for Ebola Vaccine
As GlaxoSmithKline Plc (GSK) and other drugmakers race to develop and deploy vaccines against West Africa’s Ebola outbreak, one key question remains: who will pay?
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Backed by Gates, Affinivax Ramps up Velcro-like Vaccine Tech
A new startup with backing by the Bill & Melinda Gates Foundation called Affinivax claims it’s created a vaccine to protect against all 90 strains of pneumococcal bacteria. Now comes the hard part: scaling up, proving it in clinical trials, and making a successful business out of it.
- Categories
- Health Care
Subscribe to Our 'Business in Global Development' Newsletter!
Our new weekly LinkedIn newsletter features NextBillion's latest original articles, along with curated news, jobs, bizdev opportunities and events from our recent coverage of impact-focused business in emerging markets.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.